Table 1 Laboratory findings of the proband during the hospitalization and 3-year follow-up
Items | First Admission | First follow-up | Second follow-up | Third follow-up | Fourth follow-up | Normal Range |
|---|---|---|---|---|---|---|
Date | Mar, 2013 | Mar, 2014 | Aug, 2014 | Feb, 2016 | Jun, 2016 | |
Age (yrs) | 33 | 34 | 34 | 36 | 36 | |
SCr (μmol/L) | 250 | 270 | 306 | 537 | 647 | 31–132 |
eGFRa (ml/min/1.73m2) | 21.1 | 19.1 | 16.4 | 8.2 | 6.5 | > 90 |
SK (mmol/L) | 4.2 | 4.3 | 4.4 | 4.9 | 4.7 | 3.5–5.5 |
SMg (mmol/L) | 0.65 | NA | 0.70 | 0.99 | 0.91 | 0.65–1.20 |
SCa (mmol/L) | 1.42 | 1.63 | 1.68 | 1.81 | 1.58 | 2.11–2.52 |
SP (mmol/L) | 1.7 | 2.0 | 1.5 | 2.0 | 2.1 | 0.8–1.6 |
HCO3 (mmol/L) | 22.0 | 21.0 | 20.0 | 23.7 | 21.7 | 23.0–31.0 |
ALB (g/L) | 37.2 | NA | 47.8 | 39.6 | 46.5 | 35.0–55.0 |
ALP (U/L) | 40.8 | NA | NA | NA | 60.9 | 35–125 |
PTH (pg/ml) | 65.6 | 74.5 | 75.6 | 73.8 | 94.5 | 15.0–65.0 |
UpH | 5.0 | 5.0 | NA | NA | NA | |
24 h-UCa (mmol/1.73m2) | 3.9 | 4.3 | 3.8 | 2.1 | 2.0 | 2.5–5.5 |
UCa/Cr (mol/mol) | NA | 0.61 | 0.57 | 0.46 | 0.44 | 0.15–0.33 |
24 h-UMg (mmol/1.73m2) | NA | 7.1 | 7.0 | 3.9 | 4.2 | |
FEMgb | NA | 38.5% | 43.7% | 35.9% | 52.7% | < 5.0% |
25OH-VitD | NA | NA | NA | NA | 22.4 | 20.0—32.0 |
UProtein | 1.07 g/24 h | + | NA | NA | + | Negative |